© 2005 Oxford University Press
CORRESPONDENCE |
Re: Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial
Correspondence to: Ian Kunkler, FRCR, Department of Clinical Oncology, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, United Kingdom (e-mail: i.kunkler@ed.ac.uk).
| The first 10% of the full text of this article appears below. |
The paper of Ragaz et al. (1) provides important level 1 evidence that the improvement in overall survival from the addition of postmastectomy radiotherapy to systemic therapy in axillary lymph node-positive patients, previously reported (2), is sustained up to 20 years.
Ragaz et al. rightly identify the
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2005 97: 1163-1164.